Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration

Retina

Volumn 34, Issue 2, 2014, Pages 281-287

  Iacono, Pierluigi ^a   Parodi, Maurizio B ^b   Introini, Ugo ^b   La Spina, Carlo ^b   Varano, Monica ^a   Bandello, Francesco ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Age related macular degeneration; Anti VEGF; Intravitreal ranibizumab; Subfoveal choroidal neovascularization

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; LASER COAGULATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; RETINA MACULA DEGENERATION; RETINA MACULA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; VERY ELDERLY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; MALE; PROSPECTIVE STUDIES; RETINAL HEMORRHAGE; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84893304766     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182979e33     Document Type: Article

References (28)

1. Cohen SY, Creuzot-Garcher C, Darmon J, et al. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol 2007;91: 1173-1176.
2. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16: 183-189.
3. Heriot W. Intravitreal gas and rtPA: an outpatient procedure for subretinal hemorrhage. Paper presented at Vail Vitrectomy Meeting, Vail, CO, March 1996.
4. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106: 1900-1906.
5. Handwerger BA, Blodi BA, Chandra SR, et al. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol 2001;119: 28-32.
6. Haupert CL, McCuen BW II, Jaffe GJ, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 2001;131: 208-215.
7. Bressler NM, Bressler SB, Childs AL, et al; Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 2004;111: 1993-2006.
8. Olivier S, Chow DR, Packo KH, et al. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 2004;111:1201-1208.
9. Erratum in: Ophthalmology 2004;111:1640.
10. Singh RP, Patel C, Sears JE. Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator. Br J Ophthalmol 2006;90: 429-431.
11. Sacu S, Stifter E, Vécsei-Marlovits PV, et al. Management of extensive subfoveal haemorrhage secondary to neovascular agerelated macular degeneration. Eye (Lond) 2009;23: 1404-1410.
12. Fine HF, Iranmanesh R, Del Priore LV, et al. Surgical outcomes after massive subretinal hemorrhage secondary to agerelated macular degeneration. Retina 2010;30: 1588-1594.
13. Hillenkamp J, Surguch V, Framme C, et al. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 2010;248: 5-11.
14. Sandhu SS, Manvikar S, Steel DH. Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 2010;4: 637-642.
15. Bakri SJ, Nickel J, Yoganathan P, Beer PM. Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2006;37: 278-283.
16. Stifter E, Michels S, Prager F, et al. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage. Am J Ophthalmol 2007;144: 886-892.
17. Chang MA, Do DV, Bressler SB, et al. Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina 2010;30: 1171-1176.
18. McKibbin M, Papastefanou V, Matthews B, et al. Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration. Eye (Lond) 2010;24: 994-998.
19. Shienbaum G, Garcia Filho CA, Flynn HW Jr, et al. Management of submacular hemorrhage secondary to neovascular agerelated macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol 2013;S0002- S9394(13)00068-8.[in press]. doi:pii.
20. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355: 1419-1431.
21. Reynders S, Lafaut BA, Aisenbrey S, et al. Clinicopathologic correlation in hemorrhagic age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2002;240: 279-285.
22. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999;213: 97-102.
23. Steel DH, Sandhu SS. Submacular haemorrhages associated with neovascular age-related macular degeneration. Br J Ophthalmol 2011;95: 1051-1057.
24. Brown DM, Kaiser PK, Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355: 1432-1444.
25. Ollivier V, Bentolila S, Chabbat J, et al. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood 1998;91: 2698-2703.
26. Ollivier V, Chabbat J, Herbert JM, et al. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Arterioscler Thromb Vasc Biol 2000;20: 1374-1381.
27. Hollborn M, Kohen L, Werschnik C, et al. Activated blood coagulation factor X (FXa) induces angiogenic growth factor expression in human retinal pigment Epithelial cells. Invest Ophthalmol Vis Sci 2012;53: 5930-5939.
28. Hollborn M, Petto C, Steffen A, et al. Effects of thrombin on RPE cells are mediated by transactivation of growth factor receptors. Invest Ophthalmol Vis Sci 2009;50: 4452-4459.